Dan Scott
About Dan Scott
Dan Scott is a Clinical Strategy and Development Manager at HeliosX Group, where he has worked since 2022. He has extensive experience in clinical and pharmacy operations, with a strong educational background in pharmacy and management from Trinity College Dublin and the Royal College of Surgeons in Ireland.
Work at HeliosX Group
Dan Scott has been serving as the Clinical Strategy and Development Manager at HeliosX Group, which includes Dermatica and MedExpress, since 2022. In this role, he focuses on developing clinical strategies to enhance patient care and operational efficiency. Prior to this position, he worked as the Clinical and Pharmacy Operations Manager at HeliosX Group from 2021 to 2022, where he managed clinical operations and pharmacy services.
Education and Expertise
Dan Scott holds multiple degrees from Trinity College Dublin, including a Bachelor of Science in Pharmacy, a Master of Science in Management, and an Executive MBA. He also earned a Master of Pharmacy from the Royal College of Surgeons in Ireland. Additionally, he completed a Postgraduate Certificate in Clinical Exercise from Trinity College Dublin. His educational background equips him with a strong foundation in both clinical and management practices.
Background
Dan Scott has a diverse professional background in the healthcare sector. He began his career as a Pharmacy Intern at Tallaght University Hospital in 2016. He has held various roles, including Patient Care Pharmacist at Echo and Clinical Author at Numan. His experience extends to founding M3 at ZINC and working in special projects at Uniphar Group. He has also contributed to growth initiatives at Forward Health.
Professional Experience
Dan Scott's professional experience spans several roles in the healthcare industry. He worked as a Patient Care Pharmacist at Echo from 2020 to 2021 and served as a Clinical Author at Numan for a brief period in 2021. His role as M3 Founder at ZINC lasted for six months in 2019. He also engaged in various positions at Forward Health, including roles in community and growth from 2018 to 2019.